Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bouza

Showing results (71-80 of 494) with videos related to

Pageof 50
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|October 1, 1996
[Monitoring anti-retroviral treatment]J M Miró, T Pumarola, V Soriano, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolatesF García-Garrote, E Cercenado, L Alcalá, et al.
Archives of Internal Medicine|May 1, 1992
Thalidomide in patients with acquired immunodeficiency syndromeE Bouza, P Muñoz, M D Diaz, et al.
Revista Clinica Espanola|January 24, 1998
[Current status of resistance of Staphylococcus in Spain. 4th National Study (1996). Work Group on the Study of Staphylococcus]E Cercenado, C Sánchez-Carrillo, L Alcalá, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|June 20, 2008
[Zygomycetes and zygomycosis in the new era of antifungal therapies]M Torres-Narbona, J Guinea, P Muñoz, et al.
Journal of Chemotherapy (Florence, Italy)|May 1, 1997
The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerationsW R Wilson, E Bouza, H Lode, et al.
Diagnostic Microbiology and Infectious Disease|February 17, 1999
In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolatesL Alcalá, E Cercenado, F García-Garrote, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory PathogensF Marco, E Bouza, J García-de-Lomas, et al.
Revista Clinica Espanola|April 1, 1997
[Fungal infections in patients with solid tumors and other immunodepressed patients]P Muñoz García-Paredes, A Menasalvas Ruiz, E Bouza Santiago
Chest|July 1, 1977
Paracoccidioidomycosis (South American Blastomycosis) in the United StatesE Bouza, D J Winston, J Rhodes, et al.
Pageof 50

Showing results (71-80 of 494) with videos related to

Sort By:
Pageof 50
Enfermedades Infecciosas Y Microbiologia Clinica|October 1, 1996
[Monitoring anti-retroviral treatment]J M Miró, T Pumarola, V Soriano, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolatesF García-Garrote, E Cercenado, L Alcalá, et al.
Archives of Internal Medicine|May 1, 1992
Thalidomide in patients with acquired immunodeficiency syndromeE Bouza, P Muñoz, M D Diaz, et al.
Revista Clinica Espanola|January 24, 1998
[Current status of resistance of Staphylococcus in Spain. 4th National Study (1996). Work Group on the Study of Staphylococcus]E Cercenado, C Sánchez-Carrillo, L Alcalá, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|June 20, 2008
[Zygomycetes and zygomycosis in the new era of antifungal therapies]M Torres-Narbona, J Guinea, P Muñoz, et al.
Journal of Chemotherapy (Florence, Italy)|May 1, 1997
The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerationsW R Wilson, E Bouza, H Lode, et al.
Diagnostic Microbiology and Infectious Disease|February 17, 1999
In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolatesL Alcalá, E Cercenado, F García-Garrote, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory PathogensF Marco, E Bouza, J García-de-Lomas, et al.
Revista Clinica Espanola|April 1, 1997
[Fungal infections in patients with solid tumors and other immunodepressed patients]P Muñoz García-Paredes, A Menasalvas Ruiz, E Bouza Santiago
Chest|July 1, 1977
Paracoccidioidomycosis (South American Blastomycosis) in the United StatesE Bouza, D J Winston, J Rhodes, et al.
Pageof 50